Tracking the Evolution of Circulating Exosomal-Pd-L1 to Monitor Melanoma Patients

Journal of Extracellular Vesicles - Sweden
doi 10.1080/20013078.2019.1710899
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Circulating Tumour DNA for Monitoring Treatment Response to Anti-Pd-1 Immunotherapy in Melanoma Patients

Acta Dermato-Venereologica
DermatologyMedicine
2017English

Circulating Tumor DNA to Monitor Treatment Response and Detect Acquired Resistance in Patients With Metastatic Melanoma

Oncotarget
Oncology
2015English

790 Lipogenesis Governs PD-L1-dependent Immune Escape to Promote Melanoma Growth

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2019English

PD-L1 Expression in Melanoma: A Quantitative Immunohistochemical Antibody Comparison

Clinical Cancer Research
Cancer ResearchOncology
2017English

Upregulation of Circulating PD-L1/PD-1 Is Associated With Poor Post-Cryoablation Prognosis in Patients With HBV-Related Hepatocellular Carcinoma

PLoS ONE
Multidisciplinary
2011English

Detection of Circulating Melanoma Cells in the Blood of Melanoma Patients

Melanoma Research
DermatologyCancer ResearchOncology
2015English

PD-L1 Expressing Circulating Tumour Cells in Head and Neck Cancers

BMC Cancer
Cancer ResearchOncologyGenetics
2017English

Profiling of Circulating Exosomal miRNAs in Patients With Waldenström Macroglobulinemia

PLoS ONE
Multidisciplinary
2018English

Exosomal PD-L1 Promotes Tumor Growth Through Immune Escape in Non-Small Cell Lung Cancer

Experimental and Molecular Medicine
BiochemistryMedicineClinical BiochemistryMolecular BiologyMolecular Medicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy